Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Change in Working Capital history
Currency unavailable · from the cash flow
No Change in Working Capital data reported for this period type.
Change in Working Capital vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $37.35M USD | -51.6% | — | 4.2% | |
| LTM Mar 2026 | €1.55M EUR | -127.9% | +296.7% | 9.5% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | -89.8% | +296.7% | 6.8% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.